NOT RECOMMENDED FOR PUBLICATION File Name: 24a0120n.06
No. 23-3465 FILED UNITED STATES COURT OF APPEALS Mar 14, 2024 FOR THE SIXTH CIRCUIT KELLY L. STEPHENS, Clerk ) UNITED STATES OF AMERICA, ) ON APPEAL FROM THE Plaintiff-Appellee, ) UNITED STATES DISTRICT ) COURT FOR THE v. ) NORTHERN DISTRICT OF ) OHIO DANIEL GWIN, ) Defendant-Appellant. ) OPINION )
Before: COLE, CLAY, and BLOOMEKATZ, Circuit Judges.
BLOOMEKATZ, Circuit Judge. In 2022, Daniel Gwin pleaded guilty to nine felony counts
stemming from his role in a conspiracy at his workplace. Gwin was a manager at a family-owned
medical research center that we refer to as “Company 1.” Gwin, along with seven other Company
1 employees, fabricated the results of clinical trials for recently developed medications, which
pharmaceutical companies then presented to federal regulators in seeking approval to make these
new drugs available to the public.
The district court sentenced Gwin to a below-guidelines sentence of 30-months’
imprisonment. Gwin claims that this sentence was both procedurally and substantively
unreasonable, arguing that the district court did not sufficiently explain why it sentenced him to
several more months than two of his coconspirators, and that it did not adequately weigh the
mitigating factors which, in his view, mandated a lesser sentence. Because the district court did
not abuse its discretion in sentencing Gwin, we affirm. No. 23-3465, United States v. Gwin
FACTUAL BACKGROUND
In 2012, Daniel Gwin began a position as a study coordinator at Company 1. Company 1
was a research organization owned by Amie Demming and Debra Adamson—a mother and
daughter team—with offices in Ohio and Tennessee. The company employed multiple family
members, including William and Ashley Adamson, but Gwin was not related. Company 1
conducted FDA-required clinical trials of investigative drugs for pharmaceutical companies.
Clinical trials are necessary to ensure that a pharmaceutical company’s new drug is safe and
effective for human use. As a study coordinator in the Cleveland-area office, Gwin was responsible
for managing the trials for various of Company 1’s clients, and in doing so he supervised other
research employees.
The conspiracy began in 2013, about six months after Gwin took the job. Demming was
the ringleader and developed the scheme when the company began to face financial troubles. Gwin
states that Demming harassed, bullied, and intimidated him, and that he feared losing his job if he
did not participate in the scheme.
The scheme, roughly described, was as follows: Company 1 employees falsely inflated the
number of research participants in the clinical trials, then Company 1 billed its clients for the
nonexistent work. Gwin and his colleagues fabricated test subjects from whole cloth, registered
patients for studies without consent, falsified laboratory results, and collected payment for each
phony participant. At times, Gwin even substituted his own blood and medical information for that
of real study participants. As a study coordinator, Gwin signed informed consent forms for other
employees who fraudulently registered themselves in clinical trials. Company 1 sent these false
clinical results to its pharmaceutical clients, who then submitted the results to the FDA in seeking
approval that their drugs were safe and effective.
-2- No. 23-3465, United States v. Gwin
Because Gwin’s claim rests on the alleged sentencing disparity with his coconspirators, we
describe not only his culpability, but also that of William and Ashley Adamson, whom Gwin points
to as the most relevant comparators. William and Ashley Adamson were Amie Demming’s brother
and sister-in-law, and they managed the Tennessee offices.
The three employees were responsible for similar amounts of economic loss. During the
course of the conspiracy, eight pharmaceutical companies paid Company 1 a total of $6,552,903
for—unbeknownst to them—fraudulent clinical trials. Gwin was personally responsible for little
over $2.8 million of that amount, the third highest of the defendants. William Adamson caused
$2.72 million in loss and Ashley Adamson caused $2.94 million in loss.
The three employees were also paid under a similar compensation structure. Company 1
paid Gwin and the Adamsons an annual salary and a year-end bonus. The bonus was based on the
company’s profits and the employee’s individual performance, which was tied to the number of
patients the employee enrolled in studies. Gwin had a starting salary of $43,500, and Ashley
Adamson, who began around the same time, had a starting salary $41,600. No party argued that
their salaries differed markedly in subsequent years. In their first years, Gwin and Ashley Adamson
received bonuses of $500 and $1,800, respectively, while the next year they received $1,500 and
$1,800, respectively.
The three employees’ pleas, however, looked different. The Adamsons pleaded guilty to
one count of conspiracy to commit mail fraud and wire fraud. The district court sentenced William
to 22 months’ imprisonment and Ashley to 27 months.
Gwin pleaded guilty to nine counts—one count of conspiracy to commit mail fraud and
wire fraud, seven counts of mail fraud, and one count of conspiracy to defraud the United States.
At sentencing, the court granted Gwin a three-level reduction for acceptance of responsibility.
-3- No. 23-3465, United States v. Gwin
That, combined with Gwin’s lack of criminal history, resulted in a range of 33 to 41 months under
the Sentencing Guidelines. After weighing the aggravating and mitigating factors, the district court
varied downward, giving Gwin a below-guidelines sentence of 30-months in prison followed by
three years of supervised release, a mandatory $900 special assessment, and $2,841,792 in
restitution.
ANALYSIS
On appeal, Gwin argues that his sentence was both procedurally and substantively
unreasonable. We review both his procedural and substantive reasonableness claims for an abuse
of discretion. Gall v. United States, 552 U.S. 38, 41 (2007).1 We address each challenge in turn.
I. Procedural Reasonableness In reviewing whether a sentence was procedurally unreasonable, we look to see whether
the district court “(1) properly calculated the applicable advisory Guidelines range; (2) considered
the other § 3553(a) factors as well as the parties’ arguments for a sentence outside the Guidelines
range; and (3) adequately articulated its reasoning for imposing the particular sentence chosen,
including any . . . decision to deviate from the advisory Guidelines range” or rejection of the
parties’ arguments that it should deviate. United States v. Bolds, 511 F.3d 568, 581 (2007).
Gwin urges us to reverse on the third requirement, arguing that the district court did not
adequately articulate why he received a longer sentence than either William or Ashley Adamson.
He emphasizes that he received the second highest sentence in the conspiracy—just behind
1 The government urges us to review the procedural reasonableness claim for plain error rather than for an abuse of discretion because it says that Gwin did not adequately preserve his objection at the sentencing hearing.
Free access — add to your briefcase to read the full text and ask questions with AI
NOT RECOMMENDED FOR PUBLICATION File Name: 24a0120n.06
No. 23-3465 FILED UNITED STATES COURT OF APPEALS Mar 14, 2024 FOR THE SIXTH CIRCUIT KELLY L. STEPHENS, Clerk ) UNITED STATES OF AMERICA, ) ON APPEAL FROM THE Plaintiff-Appellee, ) UNITED STATES DISTRICT ) COURT FOR THE v. ) NORTHERN DISTRICT OF ) OHIO DANIEL GWIN, ) Defendant-Appellant. ) OPINION )
Before: COLE, CLAY, and BLOOMEKATZ, Circuit Judges.
BLOOMEKATZ, Circuit Judge. In 2022, Daniel Gwin pleaded guilty to nine felony counts
stemming from his role in a conspiracy at his workplace. Gwin was a manager at a family-owned
medical research center that we refer to as “Company 1.” Gwin, along with seven other Company
1 employees, fabricated the results of clinical trials for recently developed medications, which
pharmaceutical companies then presented to federal regulators in seeking approval to make these
new drugs available to the public.
The district court sentenced Gwin to a below-guidelines sentence of 30-months’
imprisonment. Gwin claims that this sentence was both procedurally and substantively
unreasonable, arguing that the district court did not sufficiently explain why it sentenced him to
several more months than two of his coconspirators, and that it did not adequately weigh the
mitigating factors which, in his view, mandated a lesser sentence. Because the district court did
not abuse its discretion in sentencing Gwin, we affirm. No. 23-3465, United States v. Gwin
FACTUAL BACKGROUND
In 2012, Daniel Gwin began a position as a study coordinator at Company 1. Company 1
was a research organization owned by Amie Demming and Debra Adamson—a mother and
daughter team—with offices in Ohio and Tennessee. The company employed multiple family
members, including William and Ashley Adamson, but Gwin was not related. Company 1
conducted FDA-required clinical trials of investigative drugs for pharmaceutical companies.
Clinical trials are necessary to ensure that a pharmaceutical company’s new drug is safe and
effective for human use. As a study coordinator in the Cleveland-area office, Gwin was responsible
for managing the trials for various of Company 1’s clients, and in doing so he supervised other
research employees.
The conspiracy began in 2013, about six months after Gwin took the job. Demming was
the ringleader and developed the scheme when the company began to face financial troubles. Gwin
states that Demming harassed, bullied, and intimidated him, and that he feared losing his job if he
did not participate in the scheme.
The scheme, roughly described, was as follows: Company 1 employees falsely inflated the
number of research participants in the clinical trials, then Company 1 billed its clients for the
nonexistent work. Gwin and his colleagues fabricated test subjects from whole cloth, registered
patients for studies without consent, falsified laboratory results, and collected payment for each
phony participant. At times, Gwin even substituted his own blood and medical information for that
of real study participants. As a study coordinator, Gwin signed informed consent forms for other
employees who fraudulently registered themselves in clinical trials. Company 1 sent these false
clinical results to its pharmaceutical clients, who then submitted the results to the FDA in seeking
approval that their drugs were safe and effective.
-2- No. 23-3465, United States v. Gwin
Because Gwin’s claim rests on the alleged sentencing disparity with his coconspirators, we
describe not only his culpability, but also that of William and Ashley Adamson, whom Gwin points
to as the most relevant comparators. William and Ashley Adamson were Amie Demming’s brother
and sister-in-law, and they managed the Tennessee offices.
The three employees were responsible for similar amounts of economic loss. During the
course of the conspiracy, eight pharmaceutical companies paid Company 1 a total of $6,552,903
for—unbeknownst to them—fraudulent clinical trials. Gwin was personally responsible for little
over $2.8 million of that amount, the third highest of the defendants. William Adamson caused
$2.72 million in loss and Ashley Adamson caused $2.94 million in loss.
The three employees were also paid under a similar compensation structure. Company 1
paid Gwin and the Adamsons an annual salary and a year-end bonus. The bonus was based on the
company’s profits and the employee’s individual performance, which was tied to the number of
patients the employee enrolled in studies. Gwin had a starting salary of $43,500, and Ashley
Adamson, who began around the same time, had a starting salary $41,600. No party argued that
their salaries differed markedly in subsequent years. In their first years, Gwin and Ashley Adamson
received bonuses of $500 and $1,800, respectively, while the next year they received $1,500 and
$1,800, respectively.
The three employees’ pleas, however, looked different. The Adamsons pleaded guilty to
one count of conspiracy to commit mail fraud and wire fraud. The district court sentenced William
to 22 months’ imprisonment and Ashley to 27 months.
Gwin pleaded guilty to nine counts—one count of conspiracy to commit mail fraud and
wire fraud, seven counts of mail fraud, and one count of conspiracy to defraud the United States.
At sentencing, the court granted Gwin a three-level reduction for acceptance of responsibility.
-3- No. 23-3465, United States v. Gwin
That, combined with Gwin’s lack of criminal history, resulted in a range of 33 to 41 months under
the Sentencing Guidelines. After weighing the aggravating and mitigating factors, the district court
varied downward, giving Gwin a below-guidelines sentence of 30-months in prison followed by
three years of supervised release, a mandatory $900 special assessment, and $2,841,792 in
restitution.
ANALYSIS
On appeal, Gwin argues that his sentence was both procedurally and substantively
unreasonable. We review both his procedural and substantive reasonableness claims for an abuse
of discretion. Gall v. United States, 552 U.S. 38, 41 (2007).1 We address each challenge in turn.
I. Procedural Reasonableness In reviewing whether a sentence was procedurally unreasonable, we look to see whether
the district court “(1) properly calculated the applicable advisory Guidelines range; (2) considered
the other § 3553(a) factors as well as the parties’ arguments for a sentence outside the Guidelines
range; and (3) adequately articulated its reasoning for imposing the particular sentence chosen,
including any . . . decision to deviate from the advisory Guidelines range” or rejection of the
parties’ arguments that it should deviate. United States v. Bolds, 511 F.3d 568, 581 (2007).
Gwin urges us to reverse on the third requirement, arguing that the district court did not
adequately articulate why he received a longer sentence than either William or Ashley Adamson.
He emphasizes that he received the second highest sentence in the conspiracy—just behind
1 The government urges us to review the procedural reasonableness claim for plain error rather than for an abuse of discretion because it says that Gwin did not adequately preserve his objection at the sentencing hearing. We need not decide the preservation question because Gwin’s challenge fails even when we review for an abuse of discretion, as we do when an objection is adequately preserved.
-4- No. 23-3465, United States v. Gwin
Demming, the leader—even though his calculated loss was less than Ashley Adamson’s
(27 months), and he did not substantially benefit from the conspiracy because he was not a family
member, like William Adamson (22 months). He characterizes the district court’s analysis as
disregarding his culpability relative to his coconspirators. But that’s not accurate.
The district court carefully considered the comparative sentences of the coconspirators in
sentencing Gwin. Before it made its decision, the district court discussed the other defendants and
specifically asked whether Ashley and William Adamson were relevant comparators in terms of
culpability. In response, the government compared these three coconspirators with respect to the
amount of loss they caused, their financial gains, and their levels of participation in the conduct
comprising the conspiracy.
After the parties concluded their arguments and the district court turned to its sentencing
analysis, the court twice mentioned its desire to avoid unwanted sentencing disparities. It first said
that it “need[ed] to determine the need for the sentence imposed, keeping in mind all of the factors,
including the need to avoid unwarranted sentencing disparities among defendants with similar
records who have been found guilty of similar conduct.” Sent’g Tr., R. 341, PageID 2361. It also
noted that the circumstances of Gwin’s case were particularly “alarming” given Gwin’s “training
and . . . that he was entrusted to train others.” Id. at PageID 2362. The district court then went on
to say, yet again, that it had to reach a decision that “not only avoid[ed] unwarranted sentencing
disparities among the group of national defendants with similar records who have been found
guilty of similar conduct” but also “to some degree” the “other codefendants in this case.” Id. at
PageID 2363. The court explained that each codefendant’s sentence was based on “their own
unique backgrounds and characteristics and their own unique involvement in the crime or crimes
that were committed.” Id.
-5- No. 23-3465, United States v. Gwin
The district court sentenced Gwin to three more months than Ashley Adamson and eight
more months than William Adamson. While the district court did not explicitly address the several-
month difference, it did not have to. See United States v. Duane, 533 F.3d 441, 451–52 (6th Cir.
2008). And the three coconspirators, even if comparable, were not entirely similarly situated. The
Adamsons pleaded to only one count, compared to Gwin’s nine. See United States v. Conatser,
514 F.3d 508, 522 (6th Cir. 2008) (“Disparities between the sentences of coconspirators can exist
for valid reasons, such as . . . the offenses of conviction.”). The district court also considered
aggravating factors unique to Gwin. As the court mentioned, Gwin was one of the few employees
that interfaced with clients, and, on one occasion, he even handed fabricated evidence to a client
asking questions about his clinical trial. He also had a trusted role in the field and abused that trust.
Gwin, however, argues that the district court’s decision was procedurally deficient for not
accounting for the several-month difference. The best case he cites is United States v. Wallace, in
which we reversed a sentence that was twice as long as that of a coconspirator who played a bigger
role in the conspiracy. 597 F.3d 794, 803–804 (6th Cir. 2010). There, the government’s arguments
explaining the disparity “were never adopted or even acknowledged by the district judge.” Id. at
802. We stressed that “no part of the sentencing transcript” showed that the lower court “ever
considered” the disparity. Id. That is not the case here, as Gwin even admits that the district court
addressed the issue—he just disagrees with its resolution. Further, the defendant in Wallace was
sentenced to twice as much time as her co-conspirator. Id. The alleged disparity between the
Adamsons’ sentences and Gwin’s sentence—eight and three months respectively—is nowhere
near as stark. We thus conclude that there was no procedural unreasonableness in Gwin’s
sentencing.
-6- No. 23-3465, United States v. Gwin
II. Substantive Reasonableness Next, we decide whether Gwin’s sentence was substantively unreasonable. In answering
that question, we turn to 18 U.S.C. § 3553(a) and determine whether the district court considered
the relevant sentencing factors. United States v. Robinson, 778 F.3d 515, 519 (6th Cir. 2015). “A
sentence is substantively reasonable if it is proportionate to the seriousness of the circumstances
of the offense and offender, and sufficient but not greater than necessary, to comply with the
purposes of § 3553(a).” Id. (internal quotation marks omitted). Conversely, we will find a sentence
substantively unreasonable if the defendant shows that the district court selected a sentence
“arbitrarily,” based the sentence on “impermissible factors,” failed to consider relevant sentencing
factors, or gave “an unreasonable amount of weight” to any pertinent factor. Conatser, 514 F.3d
at 520. We presume that a below-guidelines sentence, as we have here, is reasonable. United States
v. Harris, 636 F. App’x 922, 929 (6th Cir. 2016); United States v. Greco, 734 F.3d 441, 450 (6th
Cir. 2013) (stating that defendants seeking to overturn a below-guidelines sentence “bear a heavy
burden.”).
As the sentencing transcript reveals, the district court carefully weighed the § 3553(a)
factors. In explaining the sentence, the district court stressed mitigating factors such as Gwin’s two
children, lack of priors, difficult childhood, accusations of workplace harassment, and fear of
losing his job. It also pointed to aggravating factors, such as Gwin’s years-long participation in the
scheme, harm to pharmaceutical clients, experience and training in clinical research, dishonest
interactions with patients and clients, and falsification of records using his own medical data. The
court, evidently finding the mitigating factors compelling, varied down one level.
Gwin challenges how the district court weighed the § 3553(a) factors, contending that the
district court put too much emphasis on Gwin’s conduct relative to others in the conspiracy and
-7- No. 23-3465, United States v. Gwin
not enough emphasis on his lack of criminal history, the pressure he was under to join the
conspiracy, and his low likelihood of recidivism. Because the court mentioned neither deterrence
nor public protection, Gwin argues that the court undervalued those considerations.
These arguments show, at most, that the factors could have been weighed differently, not
that the district court abused its discretion in weighing them here. See Conatser, 514 F.3d at 520–
23. The district court’s failure to recite concepts like recidivism and deterrence does not undermine
its conclusion. The district court need not discuss each factor individually or address every
argument relating to those factors. United States v. Gale, 468 F.3d 929, 940 (6th Cir. 2006). Rather,
the district court’s detailed explanation assures us that it carefully considered all the relevant
information presented by the parties in light of the § 3553(a) factors, including mitigation
evidence. Therefore, Gwin’s challenge to the substantive reasonableness of his sentence fails.
CONCLUSION
Because the district court did not abuse its discretion in sentencing Gwin, we affirm its
judgment.
-8-